+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

India Nicotine Replacement Therapy Market Size, Share & Trends Analysis Report by Product (Gums, Lozenges), Strength (2 mg, 4 mg), Distribution Channel (Online, Offline, Hospital Pharmacies, Retail Pharmacies), and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 120 Pages
  • December 2023
  • Region: India
  • Grand View Research
  • ID: 5921053
The India nicotine replacement therapy market size is expected to reach USD 75.74 million by 2030, registering a CAGR 12.56% from 2024 to 2030, according to the study. The substantially high magnitude of India's tobacco user base, regional socioeconomic disparities, and the significant financial burdens associated with tobacco use boost the nicotine replacement therapy market & its role in addressing these challenges. The growing awareness of these issues, supported by government initiatives and collaborative efforts, presents a substantial growth opportunity for NRT products in India.

The inclusion of NRT in the National List of Essential Medicines (NLEM) in September 2022 marks a significant milestone. This move is poised to enhance accessibility and affordability. However, price capping could slow down market growth. Rigorous tobacco scrutiny ads and regulations have contributed to increased awareness about the risks associated with smoking, prompting individuals to seek safer alternatives like NRT. India has a well-defined regulatory framework for pharmaceuticals and healthcare products, which can provide a clear pathway for the legal approval & distribution of NRTs. Moreover, existing tobacco control laws and regulations can create a favorable legal environment for adopting NRTs as a harm reduction strategy.

Widespread retail expansion is expected to improve the accessibility of NRT products in India. Expansion of the retail sector in India is enhancing the accessibility of NRT products. It goes beyond mere convenience, highlighting the profound impact of this expansion on affordability, awareness, and the broader effort to provide effective smoking cessation solutions to a wider range of consumers in India.

Due to the expansion, NRT products are accessible beyond urban centers, ensuring that individuals in semi-urban and rural areas can access these smoking cessation aids. In addition, it improves affordability by fostering competition among retailers, making NRT more cost-effective. Furthermore, the visible placement of NRT products in retail outlets enhances awareness and normalizes conversations about quitting smoking. The convenience of purchasing products locally or online aligns with the lifestyles of several individuals in India, reducing tobacco consumption.

Affordability has remained a persistent challenge in terms of accessibility to NRT, particularly for low-income individuals residing in rural India. This obstacle posed difficulties in effectively combating tobacco addiction among this demographic. Despite efforts to these products NRT more affordable, insurance coverage remains the leading challenge. The lack of adequate financial support continues to hinder the most vulnerable populations from accessing smoking cessation aids.

India Nicotine Replacement Therapy Market Report Highlights

  • Based on product, gums dominated the market in 2023 due to increasing emphasis on NRTs and growing involvement of the government, and developments in the industry
  • Based on strength, 4 mg held the largest share of the market due to higher price of 4 mg products. Higher pricing is often seen as indicative of increased potency for heavy smokers, which appeals to consumers seeking more robust solutions to address their nicotine cravings and addiction
  • Based on distribution channel, the offline segment dominated the India nicotine replacement sector in 2023
  • Accessibility of NRT products in retail pharmacies reflects the commitment to public health and highlights the importance of making cessation aids readily available to those looking to overcome smoking addiction

Table of Contents

Chapter 1 Methodology And Scope
1.1 Segment Definitions
1.1.1 Product Segment
1.1.2 Strength Segment
1.1.3 Distribution Channel Segment
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Internal database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List Of Secondary Sources
1.11 List Of Abbreviations
1.12 Research Assumptions
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Strength And Distribution Channel Segment Snapshot
2.3 Competitive Landscape Snapshot
2.4 Penetration And Growth Prospect Mapping For Nicotine Replacement Therapy Products, 2023
Chapter 3 India Nicotine Replacement Therapy Market - State Analysis, 2018-2030 (USD Million)
3.1 India
3.1.1 Andhra Pradesh
3.1.2 Bihar
3.1.3 Chhattisgarh
3.1.4 Goa
3.1.5 Gujarat
3.1.6 Haryana
3.1.7 Himachal Pradesh
3.1.8 Jharkhand
3.1.9 Karnataka
3.1.10 Kerala
3.1.11 Madhya Pradesh
3.1.12 Maharashtra
3.1.13 Odisha
3.1.14 Punjab
3.1.15 Rajasthan
3.1.16 Sikkim
3.1.17 Tamil Nadu
3.1.18 Telangana
3.1.19 Uttar Pradesh
3.1.20 Uttarakhand
3.1.21 West Bengal
3.1.22 Andaman And Nicobar Islands
3.1.23 Chandigarh
3.1.24 Dadra & Nagar Haveli And Daman & Diu
3.1.25 Delhi
3.1.26 Jammu And Kashmir
3.1.27 Lakshadweep
3.1.28 Puducherry
3.1.29 Ladakh
3.1.30 Northeast India
Chapter 4 India Nicotine Replacement Therapy Market Variables, Trends, And Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market
4.2 Market Dynamics
4.2.1 Market Driver Analysis
4.2.1.1 Large Tobacco User Base In India
4.2.1.2 Rising Health Consciousness In India
4.2.1.3 Widespread Retail Expansion
4.2.2 Market Restraint Analysis
4.2.2.1 Poor Awareness, High Cost, And Lack Of Insurance Coverage For Nrt In Rural Areas
4.2.2.2 Preference For Traditional Remedies And Limited Availability & Variety Of Nrt Products In Rural Areas
4.3 Business Environment Analysis
4.3.1 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
4.3.2 Industry Analysis - Porter’s
4.3.3 Regulatory & Reimbursement Scenario
4.3.4 Epidemiology Analysis
4.3.5 Market Innovation And Trend Analysis
4.3.6 Consumer & Kol Insights
Chapter 5 India Nicotine Replacement Therapy Market Analysis, By City, 2018-2030 (Revenue, USD Million) (Volume, Skus In Millions)
5.1 Bangalore
5.2 Pune
5.3 Kolkata
5.4 Mumbai
5.5 Ahmedabad
5.6 Delhi Ncr
5.7 Lucknow
5.8 Visakhapatnam
5.9 Chennai
5.10 Hyderabad
5.11 Thane
5.12 Nagpur
5.13 Bhubaneswar
5.14 Jaipur
5.15 Surat
Chapter 6 India Nicotine Replacement Therapy Market - Segment Analysis, By Product, 2018-2030 (USD Million)
6.1 India Nicotine Replacement Therapy Market: Product Movement Analysis
6.2 India Nicotine Replacement Therapy Market Estimates & Forecast, By Product (USD Million)
6.2.1 Gum
6.2.2 Lozenges
6.2.3 Others
Chapter 7 India Nicotine Replacement Therapy Market - Segment Analysis, By Strength, 2018-2030 (USD Million)
7.1 India Nicotine Replacement Therapy Market: Strength Movement Analysis
7.2 India Nicotine Replacement Therapy Market Estimates & Forecast, By Strength (USD Million)
7.2.1 2 Mg
7.2.2 4 Mg
Chapter 8 India Nicotine Replacement Therapy Market - Segment Analysis, By Distribution Channel, 2018-2030 (USD Million)
8.1 India Nicotine Replacement Therapy Market: Distribution Channel Movement Analysis
8.2 India Nicotine Replacement Therapy Market Estimates & Forecast, By Distribution Channel (USD Million)
8.2.1 Online
8.2.2 Offline
8.2.2.1 Hospital Pharmacies
8.2.2.2 Retail Pharmacies
8.2.2.3 Others (Supermarkets & Other Modes)
Chapter 9 Competitive Landscape
9.1 Company Categorization
9.2 Participants' Overview
9.2.1 Company Profiles
9.2.1.1 Glenmark Pharmaceuticals Ltd.
9.2.1.1.1 Company Overview
9.2.1.1.2 Financial Performance
9.2.1.1.3 Product Benchmarking
9.2.1.1.4 Strategic Initiatives
9.2.1.2 Fertin Pharma
9.2.1.2.1 Company Overview
9.2.1.2.2 Financial Performance
9.2.1.2.3 Product Benchmarking
9.2.1.2.4 Strategic Initiatives
9.2.1.3 Rubicon Consumer Healthcare Pvt. Ltd.
9.2.1.3.1 Company Overview
9.2.1.3.2 Financial Performance
9.2.1.3.3 Product Benchmarking
9.2.1.3.4 Strategic Initiatives
9.2.1.4 Johnson & Johnson Services, Inc.
9.2.1.4.1 Company Overview
9.2.1.4.2 Financial Performance
9.2.1.4.3 Product Benchmarking
9.2.1.4.4 Strategic Initiatives
9.2.1.5 Rusan Pharma Ltd.
9.2.1.5.1 Company Overview
9.2.1.5.2 Financial Performance
9.2.1.5.3 Product Benchmarking
9.2.1.5.4 Strategic Initiatives
9.2.1.6 Cipla, Inc.
9.2.1.6.1 Company Overview
9.2.1.6.2 Financial Performance
9.2.1.9.2 Product Benchmarking
9.2.1.6.4 Strategic Initiatives
9.2.1.7 Piramal Pharma Limited
9.2.1.7.1 Company Overview
9.2.1.7.2 Financial Performance
9.2.1.7.3 Product Benchmarking
9.2.1.7.4 Strategic Initiatives
9.2.1.8 Itc Limited
9.2.1.8.1 Company Overview
9.2.1.8.2 Financial Performance
9.2.1.8.3 Product Benchmarking
9.2.1.8.4 Strategic Initiatives
9.2.1.9 Inventz Lifesciences
9.2.1.9.1 Company Overview
9.2.1.9.2 Financial Performance
9.2.1.9.3 Product Benchmarking
9.2.1.9.4 Strategic Initiatives
9.2.1.10 Sparsha Pharma International Pvt. Ltd.
9.2.1.10.1 Company Overview
9.2.1.10.2 Financial Performance
9.2.1.10.3 Product Benchmarking
9.2.1.10.4 Strategic Initiatives
9.3 Market Share Analysis
9.3.1 India Nicotine Replacement Therapy Market Share Analysis, 2023
9.3.2 India Nicotine Replacement Therapy Market Share Analysis, By Product (Gum), 2023
9.3.3 India Nicotine Replacement Therapy Market Share Analysis, By Product (Lozenges), 2023
9.4 Strategy Mapping
9.4.1 Collaboration
9.4.2 Acquisitions
9.4.3 Others
Chapter 10 Conclusion
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Tobacco Use Statistics in India, 2022
Table 4 India nicotine replacement therapy market revenue estimates and forecast, by product, 2018-2030 (USD Million)
Table 5 India nicotine replacement therapy market revenue estimates and forecast, by strength, 2018-2030 (USD Million)
Table 6 India nicotine replacement therapy market revenue estimates and forecast, by distribution channel, 2018-2030 (USD Million)
Table 7 Key companies undergoing collaboration
Table 8 Key companies undertaking acquisitions
Table 9 Key companies undergoing other strategies
List of Figures
Figure 1 India Nicotine Replacement Therapy Market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value chain based sizing & forecasting
Figure 7 QFD modelling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Market snapshot
Figure 10 Strength and distribution channel segment snapshot
Figure 11 Competitive landscape snapshot
Figure 12 Penetration and growth prospect mapping
Figure 13 India market estimates and forecast, 2018-2030 (USD Million)
Figure 14 Andhra Pradesh market estimates and forecast, 2018-2030 (USD Million)
Figure 15 Bihar market estimates and forecast, 2018-2030 (USD Million)
Figure 16 Chhattisgarh market estimates and forecast, 2018-2030 (USD Million)
Figure 17 Goa market estimates and forecast, 2018-2030 (USD Million)
Figure 18 Gujarat market estimates and forecast, 2018-2030 (USD Million)
Figure 19 Haryana market estimates and forecast, 2018-2030 (USD Million)
Figure 20 Himachal Pradesh market estimates and forecast, 2018-2030 (USD Million)
Figure 21 Jharkhand market estimates and forecast, 2018-2030 (USD Million)
Figure 22 Karnataka market estimates and forecast, 2018-2030 (USD Million)
Figure 23 Kerala market estimates and forecast, 2018-2030 (USD Million)
Figure 24 Madhya Pradesh market estimates and forecast, 2018-2030 (USD Million)
Figure 25 Maharashtra market estimates and forecast, 2018-2030 (USD Million)
Figure 26 Odisha market estimates and forecast, 2018-2030 (USD Million)
Figure 27 Punjab market estimates and forecast, 2018-2030 (USD Million)
Figure 28 Rajasthan market estimates and forecast, 2018-2030 (USD Million)
Figure 29 Sikkim market estimates and forecast, 2018-2030 (USD Million)
Figure 30 Tamil Nadu market estimates and forecast, 2018-2030 (USD Million)
Figure 31 Telangana market estimates and forecast, 2018-2030 (USD Million)
Figure 32 Uttar Pradesh market estimates and forecast, 2018-2030 (USD Million)
Figure 33 Uttarakhand market estimates and forecast, 2018-2030 (USD Million)
Figure 34 West Bengal market estimates and forecast, 2018-2030 (USD Million)
Figure 35 Andaman and Nicobar Islands market estimates and forecast, 2018-2030 (USD Million)
Figure 36 Chandigarh market estimates and forecast, 2018-2030 (USD Million)
Figure 37 Dadra & Nagar Haveli and Daman & Diu market estimates and forecast, 2018-2030 (USD Million)
Figure 38 Delhi market estimates and forecast, 2018-2030 (USD Million)
Figure 39 Jammu and Kashmir market estimates and forecast, 2018-2030 (USD Million)
Figure 40 Lakshadweep market estimates and forecast, 2018-2030 (USD Million)
Figure 41 Puducherry market estimates and forecast, 2018-2030 (USD Million)
Figure 42 Ladakh market estimates and forecast, 2018-2030 (USD Million)
Figure 43 Northeast India market estimates and forecast, 2018-2030 (USD Million)
Figure 44 Market dynamics
Figure 45 SWOT analysis, by factor (Political & legal, economic, and technological)
Figure 46 Industry analysis - Porter’s
Figure 47 Bangalore market estimates and forecast, 2018-2030 (USD Million)
Figure 48 Pune market estimates and forecast, 2018-2030 (USD Million)
Figure 49 Kolkata market estimates and forecast, 2018-2030 (USD Million)
Figure 50 Mumbai market estimates and forecast, 2018-2030 (USD Million)
Figure 51 Ahmedabad market estimates and forecast, 2018-2030 (USD Million)
Figure 52 Delhi NCR market estimates and forecast, 2018-2030 (USD Million)
Figure 53 Lucknow market estimates and forecast, 2018-2030 (USD Million)
Figure 54 Visakhapatnam market estimates and forecast, 2018-2030 (USD Million)
Figure 55 Chennai market estimates and forecast, 2018-2030 (USD Million)
Figure 56 Hyderabad market estimates and forecast, 2018-2030 (USD Million)
Figure 57 Thane market estimates and forecast, 2018-2030 (USD Million)
Figure 58 Nagpur market estimates and forecast, 2018-2030 (USD Million)
Figure 59 Bhubaneswar market estimates and forecast, 2018-2030 (USD Million)
Figure 60 Jaipur market estimates and forecast, 2018-2030 (USD Million)
Figure 61 Surat market estimates and forecast, 2018-2030 (USD Million)
Figure 62 India nicotine replacement therapy market: Product outlook and key takeaways
Figure 63 India nicotine replacement therapy market: product movement analysis
Figure 64 Gum market estimates and forecast, 2018-2030 (USD Million)
Figure 65 Lozenges market estimates and forecast, 2018-2030 (USD Million)
Figure 66 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 67 India nicotine replacement therapy market: Strength outlook and key takeaways
Figure 68 India nicotine replacement therapy market: Strength movement analysis
Figure 69 2 mg market estimates and forecast, 2018-2030 (USD Million)
Figure 70 4 mg market estimates and forecast, 2018-2030 (USD Million)
Figure 71 India nicotine replacement therapy market: Distribution channel outlook and key takeaways
Figure 72 India nicotine replacement therapy market: Distribution channel movement analysis
Figure 73 Online market estimates and forecast, 2018-2030 (USD Million)
Figure 74 Offline market estimates and forecast, 2018-2030 (USD Million)
Figure 75 Hospital pharmacies market estimates and forecast, 2018-2030 (USD Million)
Figure 76 Retail pharmacies market estimates and forecast, 2018-2030 (USD Million)
Figure 77 Others (supermarkets & other modes) market estimates and forecast, 2018-2030 (USD Million)
Figure 79 India nicotine replacement therapy market share analysis, 2023
Figure 80 India nicotine replacement therapy market share analysis, by product 2023
Figure 81 India nicotine replacement therapy market share analysis, by product 2023
Figure 82 Strategic framework

Companies Mentioned

  • Glenmark Pharmaceuticals Ltd.
  • Fertin Pharma
  • Rubicon Consumer Healthcare Pvt. Ltd.
  • Johnson & Johnson Services, Inc.
  • Rusan Pharma Ltd.
  • Cipla, Inc.
  • Piramal Pharma Limited
  • Itc Limited
  • Inventz Lifesciences
  • Sparsha Pharma International Pvt. Ltd.

Methodology

Loading
LOADING...

Table Information